Clementia Pharmaceuticals Inc (CMTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CMTA | AMGN | GILD | CELG | ILMN |
| Company | Clementia Pharmaceuticals Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 26.51 | 270.63 | 66.58 | 108.01 | 123.09 |
| High | 26.69 | 274.86 | 67.18 | 108.59 | 124.74 |
| Low | 26.28 | 269.64 | 66.36 | 107.27 | 120.82 |
| Last | 26.35 | 273.01 | 67.08 | 108.24 | 122.87 |
| Change | -0.03 | -0.53 | +0.05 | +0.11 | -1.59 |
| % Change | -0.11% | -0.19% | +0.07% | +0.10% | -1.28% |
| Volume | 716,700 | 2,467,100 | 8,467,000 | 191,230,496 | 1,254,600 |
| 20-Day Average Volume | 172,105 | 2,172,705 | 6,490,535 | 16,188,930 | 1,515,500 |
| Previous Close | 26.38 | 273.54 | 67.03 | 108.13 | 124.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 26.13 | 271.55 | 69.07 | 108.17 | 126.51 |
| 20-Day Raw Stochastic | 58.70% | 44.22% | 14.81% | 63.25% | 29.33% |
| 20-Day Relative Strength | 75.19% | 48.18% | 33.12% | 64.69% | 43.68% |
| Weighted Alpha | +4.80 | +11.15 | -20.78 | +46.30 | -37.29 |
| Today's Opinion | 100% Buy | 40% Sell | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 100% Buy | 40% Sell | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 100% Buy | 24% Buy | 88% Sell | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.49% since 04/10/19 | +3.39% since 04/17/24 | +0.22% since 04/17/24 | -1.97% since 11/13/19 | +3.87% since 04/17/24 |
| Low | 26.18 on 04/15/19 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 115.73 on 04/18/24 |
| High | 26.73 on 04/15/19 | 274.86 on 04/24/24 | 67.68 on 04/23/24 | 110.53 on 11/14/19 | 125.70 on 04/23/24 |
| 1-Month | |||||
| %Chg | +1.74% since 03/15/19 | -1.14% since 03/22/24 | -7.62% since 03/22/24 | +5.14% since 10/18/19 | -10.47% since 03/22/24 |
| Low | 25.75 on 03/19/19 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 115.73 on 04/18/24 |
| High | 26.73 on 04/15/19 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 140.07 on 03/28/24 |
| 3-Month | |||||
| %Chg | +89.43% since 01/17/19 | -10.64% since 01/24/24 | -15.65% since 01/24/24 | +13.63% since 08/20/19 | -12.86% since 01/24/24 |
| Low | 12.18 on 01/28/19 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 115.73 on 04/18/24 |
| High | 26.73 on 04/15/19 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | +166.97% since 10/17/18 | -1.13% since 10/24/23 | -14.17% since 10/24/23 | +14.14% since 05/20/19 | +5.83% since 10/24/23 |
| Low | 9.30 on 10/22/18 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 26.73 on 04/15/19 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,002,854 | 146,436,016 | 83,519,768 | 77,035,920 | 19,567,662 |
| Shares Outstanding, K | 38,059 | 536,376 | 1,245,077 | 711,714 | 159,255 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -58,130,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | N/A | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 1,122,000,000 |
| Last Quarter Net Income | N/A | 767,000,000 | 1,429,000,000 | 1,691,000,000 | -176,000,000 |
| 60-Month Beta | 0.64 | 0.58 | 0.19 | 1.41 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/08/19 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.67 | 9.97 | 10.99 | 143.06 |